Disease Comparison
Compare similarities and differences between two diseases.
Systemic Lupus Erythematosus
Moderate
4
Symptoms
2
Causes
0
Treatments
5
FAQs
VS
Basal Cell Carcinoma
Unknown
2
Symptoms
1
Causes
0
Treatments
5
FAQs
Overview
Systemic Lupus Erythematosus
Systemic lupus erythematosus, commonly called lupus, is a chronic autoimmune disease in which the immune system attacks the body’s own tissues. It can cause inflammation and damage in many parts of the body, including the skin, joints, kidneys, heart, lungs, blood cells, and nervous system. Symptoms and severity vary considerably among individuals.
Basal Cell Carcinoma
Basal cell carcinoma is the most common type of skin cancer and develops from basal cells in the skin. It most often occurs on areas exposed to ultraviolet radiation, particularly the face, scalp, ears, neck, and arms. Lesions may appear as a pearly or shiny bump, a persistent sore, a scaly patch, or an area that repeatedly bleeds or heals and returns. Early evaluation helps guide treatment.
Symptoms
Shared
None
Only in Left Disease
Blisters Itching Red Eyes Swollen Lymph NodesOnly in Right Disease
Persistent Hoarseness Sleep ParalysisCauses
Shared
GeneticsOnly in Left Disease
Autoimmune DisorderOnly in Right Disease
None
Diagnosis
Systemic Lupus Erythematosus
Systemic lupus erythematosus is diagnosed using a combination of symptoms, physical examination, medical history, and laboratory tests. Blood tests may include antinuclear antibody testing and other tests for immune-system activity. Urine and kidney tests may be used to look for organ involvement. No single test can establish lupus in every person, so clinicians consider the overall pattern of findings.
Basal Cell Carcinoma
Basal cell carcinoma is usually suspected from the appearance of a persistent or changing skin lesion and confirmed by biopsy. A healthcare professional examines the lesion and surrounding skin and may use dermoscopy for additional visual assessment. A biopsy provides tissue for microscopic examination and establishes the diagnosis. Further imaging is generally reserved for lesions that are unusually large, deeply invasive, recurrent, or suspected of involving important nearby structures.
Prevention
Systemic Lupus Erythematosus
Systemic lupus erythematosus cannot currently be prevented in every person. People with lupus can reduce disease flares by following prescribed treatment, protecting the skin from excessive ultraviolet exposure, avoiding smoking, maintaining regular medical follow-up, and learning to recognize symptoms that may indicate increased disease activity.
Basal Cell Carcinoma
The most important preventive measure is protection from ultraviolet radiation. Using broad-spectrum sunscreen, wearing protective clothing and hats, seeking shade, and avoiding tanning beds can reduce cumulative UV exposure. Regular awareness of changing or persistent skin lesions can promote early detection. People with previous skin cancer or substantial sun exposure may benefit from regular professional skin examinations and should report suspicious lesions promptly.
Risk Factors
Systemic Lupus Erythematosus
Risk factors for systemic lupus erythematosus include genetic susceptibility, female sex, certain family histories, exposure to ultraviolet light, smoking, some infections, and particular medications. The disease is more common in women of childbearing age, although lupus can occur in people of any age or sex.
Basal Cell Carcinoma
Risk increases with cumulative ultraviolet exposure, frequent sunburns, use of tanning beds, fair skin, light-colored eyes, a tendency to burn rather than tan, and a history of significant sun exposure. Previous basal cell or other skin cancers increase future risk. Immunosuppression, previous radiation therapy, and certain inherited disorders can also increase susceptibility. Risk generally rises with age because ultraviolet damage accumulates over time.
Treatment
Systemic Lupus Erythematosus
Treatment comparison will be available soon.
Basal Cell Carcinoma
Treatment comparison will be available soon.